Compare BNR & MMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | MMLP |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.5M | 90.8M |
| IPO Year | 2019 | 2002 |
| Metric | BNR | MMLP |
|---|---|---|
| Price | $9.67 | $2.35 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 20.8K | ★ 48.4K |
| Earning Date | 06-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,653,009,000.00 |
| Revenue This Year | $111.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $3.51 | $1.89 |
| 52 Week High | $41.72 | $3.54 |
| Indicator | BNR | MMLP |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 46.81 |
| Support Level | $8.05 | $1.89 |
| Resistance Level | $9.90 | $2.83 |
| Average True Range (ATR) | 0.82 | 0.19 |
| MACD | 0.52 | -0.00 |
| Stochastic Oscillator | 84.46 | 52.27 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.